Search

Search bills, members, committees and pages...

Sign In

H.R. 1463

U.S. House•In House Committee

Summary

H.R. 1463, to prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes, was introduced in the House on Feb 21, 2025 by Rep. Brad Finstad (R) with 7 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 21, 2025: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 1463 has 7 co-sponsors.

hb1463/introduced-in-house.txt
119 HR 1463 IH: To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to “Medical Devices; Laboratory Developed Tests”, and for other purposes.
 U.S. House of Representatives
 2025-02-21
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1463  IN THE HOUSE OF REPRESENTATIVES   February 21, 2025   Mr. Finstad  (for himself and  Mr. Crenshaw ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to  Medical Devices; Laboratory Developed Tests , and for other purposes.
1.
Prohibition on funding for Food and Drug Administration rule relating to medical devices; laboratory developed tests
Notwithstanding any other provision of law, no Federal funds may be used to implement, administer, or enforce the final rule of the Food and Drug Administration relating to  Medical Devices; Laboratory Developed Tests  that was submitted for publication in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286), or any substantially similar rule.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-02-21
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Feb 21, 2025

hb1463/introduced-in-house.md

Shown Here:
Introduced in House (02/21/2025)

Sponsors

Rep. Brad Finstad (R) sponsors H.R. 1463, and 7 members have co-sponsored it, 1 of them from the day it was introduced.

Committees

H.R. 1463 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Feb 21, 2025 · 1,636 Bills

Actions

H.R. 1463 has taken 2 actions since Feb 21, 2025.

ChamberAction
Feb 21, 2025
House
Introduced in House
Feb 21, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 1463 has not gone to a roll call.

Titles

H.R. 1463 goes by 2 titles.

  • To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. — Display Title
  • To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. — Official Title as Introduced

Lobbying

3 clients hired 3 firms and 9 registered lobbyists who named H.R. 1463 in 7 quarterly filings, 2025. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Copyright/Patent/Trademark.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
COLLEGE OF AMERICAN PATHOLOGISTS—District of Columbia14—
ASSOCIATION FOR MOLECULAR PATHOLOGYA medical subspecialty professional societyMaryland12$141K
CHIPPS, CAFFREY AND DUBILIER, P. S. C.Pathology and Cytology LabKentucky11$9K

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
COLLEGE OF AMERICAN PATHOLOGISTS14—
IPOLICY SOLUTIONS12$141K
GABBERT CONSULTING CO LLC11$9K

Lobbyists

Named on the filings that cite the bill.

LobbyistFirmsClientsFilings
DARREN FENWICK114
HANNAH BURRISS114
KRISTIN MCDONALD114
MICHAEL GIULIANI114
MICHAEL HURLBUT114
JENNIFER LEIB112
LINDSEY TRISCHLER112
MEGAN ANDERSON BROOKS112
ROBERT GABBERT111

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2025 first_quarter$217.6K1st Quarter - Report
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2025 fourth_quarter$154.4K4th Quarter - Report
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2025 second_quarter$149.4K2nd Quarter - Report
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2025 third_quarter$124.8K3rd Quarter - Report
ASSOCIATION FOR MOLECULAR PATHOLOGYIPOLICY SOLUTIONS2025 second_quarter$70.5K2nd Quarter - Report
ASSOCIATION FOR MOLECULAR PATHOLOGYIPOLICY SOLUTIONS2025 first_quarter$70.5K1st Quarter - Report
CHIPPS, CAFFREY AND DUBILIER, P. S. C.GABBERT CONSULTING CO LLC2025 first_quarter$9K1st Quarter - Report

Classification

The Congressional Research Service files H.R. 1463 under Health, one of its 31 policy areas, and gives it 5 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1463’s is Health.

hr1463/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 1463 carries 5 of CRS’s legislative subjects, from Administrative law and regulatory procedures to Medical tests and diagnostic methods.

hr1463/subjects.txt
Administrative law and regulatory proceduresDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Health programs administration and fundingMedical tests and diagnostic methods

Source: congress.gov · legiscan.com